 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price(s) |
Delete |
Y1341976 |
 |
(2S)-2-[[9-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid |
98%
|
$950/1mg |
 |
Y3213468 |
 |
1-[4-(pyrimidin-5-yl)phenyl]ethan-1-amine dihydrochloride |
95%
|
$360/50mg, $520/100mg, $735/250mg, $1155/500mg, $1480/1g |
 |
Y3159319 |
 |
2-(2-phenyloxolan-2-yl)ethan-1-amine |
95%
|
$420/50mg, $605/100mg, $860/250mg, $1355/500mg, $1730/1g, $3395/2.5g, $5015/5g |
 |
Y3121464 |
 |
2-(4-Bromo-2,3-dimethylphenyl)-1,3-dioxolane |
95%
|
$815/250mg, $925/500mg |
 |
Y3168346 |
 |
2-{[(tert-butoxy)carbonyl]amino}-6-oxaspiro[3.4]octane-2-carboxylicacid |
95%
|
$420/50mg, $610/100mg, $875/250mg, $1375/500mg, $1760/1g |
 |
Y1414688 |
 |
2-Amino-1-(2,4-dimethoxyphenyl)ethanone Hydrochloride |
95%
|
$1485/1g |
 |
Y1418522 |
 |
2-Chloro-4-(methylsulfonyl)-1-nitrobenzene |
95%
|
$715/0.1g, $980/0.25g |
 |
Y3165257 |
 |
3,3-DIFLUORO-4-METHYLPENTANOIC ACID |
95%
|
$550/50mg, $820/100mg, $1170/250mg, $1840/500mg, $2360/1g, $4615/2.5g, $6825/5g |
 |
Y3129956 |
 |
3-(4-fluorobenzoyl)-1-methyl-1H-pyrazole |
95%
|
$345/50mg, $500/100mg, $715/250mg, $1120/500mg, $1430/1g |
 |
Y3211235 |
 |
3-[(prop-2-yn-1-yl)amino]cyclobutane-1-carbonitrile hydrochloride |
95%
|
$195/50mg, $270/100mg, $385/250mg, $705/500mg, $905/1g |
 |
Y3198461 |
 |
3-[4-(3-oxobutyl)phenoxy]propanoic acid |
95%
|
$125/50mg, $160/100mg, $175/250mg, $300/500mg, $430/1g |
 |
Y3159451 |
 |
4-(3-aminopropyl)-4-azatricyclo[5.2.1.0,2,6]dec-8-ene-3,5-dionehydrochloride |
95%
|
$285/50mg, $415/100mg, $575/250mg, $905/500mg, $1160/1g |
 |
Y3236260 |
 |
4-cyanopiperidine-1-carbonylchloride |
95%
|
$335/50mg, $490/100mg, $680/250mg, $1065/500mg, $1365/1g |
 |
Y3287902 |
 |
IOXITALAMIC ACID |
97%
|
$125/1mg |
 |
Y3259690 |
 |
rac-[(1R,6R,7S)-bicyclo[4.2.0]octan-7-yl]methanesulfonylfluoride |
95%
|
$575/50mg, $860/100mg, $1225/250mg, $1930/500mg, $2475/1g |
 |
Y3115287 |
 |
tert-Butyl (4-bromo-2,3-dimethylphenyl)carbamate |
95%
|
$360/1g, $1055/5g |
 |
|
|
|
 |
 |
 |